USPTO serial 79339878
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert J. Kenney
Robert J. Kenney Willcox & Savage, P.C.8201 Greensboro Drive, Suite 1001Attn.: IP AdministratorMcLean, VA 22102| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; veterinary preparations for the prevention and treatment of intestinal bacteria, colibacillosis, salmonellosis, pasteurella, brucellosis, foot-and-mouth disease, tuberculosis, plague, infectious diseases, influenza, immune related diseases and nutrient deficiency related diseases; stem cells for veterinary purposes; preparations for destroying noxious animals | ACTIVE | — |
| 042 | product quality testing of pharmaceuticals; technical research in the field of pharmaceutical studies; research and development of drugs; medical and scientific research, namely, conducting clinical trials for others; genomic structure and function analysis; genetic testing for scientific research; the testing of starting materials, intermediate products and end products of protein, cell and gene therapy pharmaceutical products | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 11, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 11, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 11, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 11, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 9, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 9, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 8, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 8, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 8, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 23, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 23, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 23, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 3, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 3, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 19, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 14, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 15, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 21, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 21, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 31, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 30, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 10, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 6, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 5, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |